Piuzzi Nicolas S, Pasqualini Ignacio, Khan Shujaa T, Springer Bryan D, Beaubien Brian C De
Department of Orthopaedic Surgery, Cleveland Clinic, Cleveland, OH, USA.
Department of Orthopaedics, Mayo Clinic, Jacksonville, FL.
J Orthop Case Rep. 2025 Jun;15(6):119-125. doi: 10.13107/jocr.2025.v15.i06.5686.
The current standard for treating chronic periprosthetic joint infection (PJI) in North America, a two-stage exchange arthroplasty, has success rates of 65-90% but involves prolonged interstage periods, increased morbidity, and a high 5-years mortality rate of up to 25%. These limitations have driven research into alternative approaches, such as intra-articular antibiotic (IAA) irrigation, which uses a specialized titanium spacer for localized antibiotic delivery over a 7-day period.
A 53-year-old male with chronic PJI of the left knee underwent a novel rapid two-stage exchange arthroplasty using an IAA irrigation system. The first stage involved implant removal and placement of a specialized antibiotic delivery IAA device. During the 7-day interstage period, high-concentration local antibiotics (tobramycin and vancomycin) were administered. The second stage, performed 1 week later, included reimplantation with a total stabilized revision knee system. At 1-year post-surgery, the patient demonstrated excellent functional recovery, pain-free mobility, and no signs of recurrent infection.
This case illustrates the potential of IAA in managing chronic PJI, offering rapid reimplantation and effective infection control. While promising, larger studies are needed to establish long-term efficacy and cost-effectiveness of this innovative approach.
北美治疗慢性人工关节周围感染(PJI)的现行标准是两阶段翻修关节成形术,成功率为65%至90%,但该方法存在阶段间隔时间长、发病率增加以及高达25%的5年高死亡率等问题。这些局限性推动了对替代方法的研究,例如关节内抗生素(IAA)冲洗,它使用一种特殊的钛制间隔器在7天内进行局部抗生素输送。
一名53岁的左膝慢性PJI男性患者接受了一种新型的快速两阶段翻修关节成形术,使用了IAA冲洗系统。第一阶段包括取出植入物并放置一个特殊的抗生素输送IAA装置。在7天的阶段间隔期内,给予高浓度局部抗生素(妥布霉素和万古霉素)。1周后进行的第二阶段包括用一个完全稳定的翻修膝关节系统重新植入。术后1年,患者功能恢复良好,活动时无痛,且无复发感染迹象。
本病例说明了IAA在治疗慢性PJI方面的潜力,可实现快速重新植入并有效控制感染。虽然前景乐观,但需要更大规模的研究来确定这种创新方法的长期疗效和成本效益。